Page 157 - 20211214_OHKF_Health_Finance_Research_Report_E (1)
P. 157
Figure 4.3c
Preferred sector for future chronic disease management consultations
30.5% 1.0%
4.6%
36.9%
27.0%
Public service providers No preference Uncertain/No opinions
Private service providers Won’t have regular visits
Factors influencing willingness to participate in the Scheme
75.3% of respondents without a prior diagnosis expressed willingness to
participate in the Scheme (Question 8). Given that many factors determine actual
participation in the Scheme and adherence to the recommended frequency of screening, we
used the WHO framework on universal access to construct and understand the factors that
may promote or inhibit participation in the Scheme. The accessibility, financial affordability,
and acceptability of the Scheme are assessed as follows.
i. Physical accessibility
In analysing the facilitators to participation, we found that physical convenience is critical.
Of the respondents who were asked about their willingness to participate in the Scheme and
who provided at least one motivation for participating, 67.5% reported geographical
convenience as either their primary or secondary reason to participate
(Question 5). Similarly, of the respondents who provided at least one motivation for seeking
care for disease management, 56.9% reported the convenience of location as
either their primary or secondary reason for choice of service provider
type (Question 11a). This highlights the importance of ensuring the physical accessibility of
service providers who will participate in the Scheme.
ii. Financial affordability
Beyond physical convenience, respondents are motivated by a reasonable price level for
screening and management services. Our survey revealed that respondents are price
sensitive to healthcare services, given that 66.0% of respondents factor the price
of services in their decision to engage in regular screening (Question 5). In
the event of having a diagnosis of a chronic condition, 58.3% of respondents
attributed reasonable service pricing as their primary or secondary
consideration in decisions on sector for follow-up care to manage their conditions
(Question 11a).
155